FDA appointment
This article was originally published in The Tan Sheet
Executive Summary
Sandra Kweder named deputy director of the Office of New Drugs effective June 1, FDA announces. Kweder joined the agency in 1988 as a medical officer in the Division of Antiviral Drug Products. She most recently served as acting director of the Office of Review Management from February 2001 through January 2002, and acting director of the Office of Drug Evaluation II from January 2002 through present...